Evidence map›Paper›PMID 27670715›Full record

ArticleJournal of molecular biology2016

An Adaptive Mutation in Enterococcus faecium LiaR Associated with Antimicrobial Peptide Resistance Mimics Phosphorylation and Stabilizes LiaR in an Activated State.

Milya Davlieva, Angel Tovar-Yanez, Kimberly DeBruler, Paul G Leonard, Michael R Zianni, Cesar A Arias, Yousif Shamoo

Abstract read
In one paragraph

Article in Journal of molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Real-time detection of response regulator phosphorylation dynamics in live bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Resistance in Vancomycin-Resistant Enterococci.Infectious disease clinics of North America · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in microbiology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Milya DavlievaDepartment of Biosciences, Rice University, Houston, TX 77005, USA.
Angel Tovar-YanezDepartment of Biosciences, Rice University, Houston, TX 77005, USA.
Kimberly DeBrulerDepartment of Biosciences, Rice University, Houston, TX 77005, USA.
Paul G LeonardCore for Biomolecular Structure and Function, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Michael R ZianniPlant-Microbe Genomics Facility, The Ohio State University, Columbus, OH 43210, USA.
Cesar A AriasUTHealth Center for Antimicrobial Resistance and Bacterial Genomics, Department of Internal Medicine, University of Texas Medical School at Houston, Houston, TX 77030, USA; Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota 110121, Colombia.
Yousif ShamooDepartment of Biosciences, Rice University, Houston, TX 77005, USA. Electronic address: shamoo@rice.edu.
Rice University · USThe Ohio State University · USThe University of Texas MD Anderson Cancer Center · USUniversidad El Bosque · CO

Funding

Defining Evolutionary Trajectories: Molecular adaptation to antibiotic resistanceR01AI080714 · NIAID · RICE UNIVERSITY · PI SHAMOO, YOUSIF · 2009 to 2023
$4.3M
Molecular Mechanisms Of Daptomycin Resistance In EnterococciR01AI093749 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2011 to 2015
$1.9M
Characterization of LiaR from multidrug-resistant E. faeciumR21AI114961 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2015 to 2016
$438k
Targeting Cell Membrane Adaptation in Multidrug-Resistant Enterococcus faeciumR21AI121519 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2017
$226k
NIAID NIH HHS R01 AI080714NIAID NIH HHS R01 AI093749NIAID NIH HHS R21 AI114961NIAID NIH HHS R21 AI121519
6 · The paper itself

Abstract

The cyclic antimicrobial lipopeptide daptomycin (DAP) triggers the LiaFSR membrane stress response pathway in enterococci and many other Gram-positive organisms. LiaR is the response regulator that, upon phosphorylation, binds in a sequence-specific manner to DNA to regulate transcription in response to membrane stress. In clinical settings, non-susceptibility to DAP by Enterococcus faecium is correlated frequently with a mutation in LiaR of Trp73 to Cys (LiaR

Indexed as

Drug Resistance, BacterialMutationAdaptation, BiologicalAnti-Bacterial AgentsBacterial ProteinsCrystallography, X-RayDaptomycinDNA, BacterialEnterococcus faeciumGene Expression Regulation, BacterialMagnetic Resonance SpectroscopyModels, MolecularMutant ProteinsOperonPhosphorylationPromoter Regions, GeneticAnti-Bacterial AgentsBacterial ProteinsDaptomycinDNA, BacterialMutant ProteinsTranscription Factorsdaptomycin resistanceE. faeciumLiaRresponse regulatorX-ray

Identifiers

PMID27670715
PMCPMC5085866
OpenAlexW2521221770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.